MXPA03000786A - Peptidos de promiostatina y metodos de usar los mismos. - Google Patents
Peptidos de promiostatina y metodos de usar los mismos.Info
- Publication number
- MXPA03000786A MXPA03000786A MXPA03000786A MXPA03000786A MXPA03000786A MX PA03000786 A MXPA03000786 A MX PA03000786A MX PA03000786 A MXPA03000786 A MX PA03000786A MX PA03000786 A MXPA03000786 A MX PA03000786A MX PA03000786 A MXPA03000786 A MX PA03000786A
- Authority
- MX
- Mexico
- Prior art keywords
- peptide
- promyostatin polypeptide
- myostatin
- promyostatin
- prodomain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
La presente invencion provee porciones peptidas sustancialmente purificadas de un polipeptido de promiostatina. Por ejemplo, la invencion provee fragmentos proteoliticos de un polipeptido de promiostatina tal como un prodominio de miostatina o un peptido de miostatina maduro, asi como porciones peptidas funcionales de un prodominio de miostatina. Tambien se provee un polipeptido de promiostatina mutante, que es resistente a corte proteolitico, por ejemplo corte en un prodominio de miostatina y un peptido de miostatina maduro. La presente invencion tambien provee un polinucleotido que codifica una porcion peptida de un polipeptido de promiostatina. En adicion, se proveen anticuerpos que se enlazan especificamente a una porcion peptida de un polipeptido de promiostatina. La invencion provee ademas metodos de identificar una porcion peptida funcional de un polipeptido de promiostatina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/628,112 US7566768B1 (en) | 1995-10-26 | 2000-07-27 | Promyostatin peptides and methods of using same |
PCT/US2001/023510 WO2002009641A2 (en) | 2000-07-27 | 2001-07-26 | Promyostatin peptides and methods of using same |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03000786A true MXPA03000786A (es) | 2004-05-21 |
Family
ID=24517522
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03000786A MXPA03000786A (es) | 2000-07-27 | 2001-07-26 | Peptidos de promiostatina y metodos de usar los mismos. |
Country Status (14)
Country | Link |
---|---|
US (3) | US7393682B1 (es) |
EP (2) | EP2360259A3 (es) |
JP (1) | JP5149478B2 (es) |
CN (2) | CN100429225C (es) |
AR (1) | AR030307A1 (es) |
AU (2) | AU8079901A (es) |
BR (1) | BRPI0112785B1 (es) |
CA (1) | CA2416260A1 (es) |
IL (2) | IL153970A0 (es) |
MX (1) | MXPA03000786A (es) |
NZ (2) | NZ542696A (es) |
PL (1) | PL210158B1 (es) |
WO (1) | WO2002009641A2 (es) |
ZA (1) | ZA200300483B (es) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7566768B1 (en) | 1995-10-26 | 2009-07-28 | The Johns Hopkins University School Of Medicine | Promyostatin peptides and methods of using same |
US7393682B1 (en) * | 1993-03-19 | 2008-07-01 | The Johns Hopkins University School Of Medicine | Polynucleotides encoding promyostatin polypeptides |
TWI329129B (en) | 2001-02-08 | 2010-08-21 | Wyeth Corp | Modified and stabilized gdf propeptides and uses thereof |
US7320789B2 (en) | 2001-09-26 | 2008-01-22 | Wyeth | Antibody inhibitors of GDF-8 and uses thereof |
US7572763B2 (en) * | 2002-02-21 | 2009-08-11 | Wyeth | Follistatin domain containing proteins |
BR0307907A2 (pt) | 2002-02-21 | 2011-07-05 | Wyeth Corp | gasp1: proteìna contendo domìnio de folistatina |
US20040138118A1 (en) * | 2002-09-16 | 2004-07-15 | Neil Wolfman | Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
AR047392A1 (es) | 2002-10-22 | 2006-01-18 | Wyeth Corp | Neutralizacion de anticuerpos contra gdf 8 y su uso para tales fines |
US20040223966A1 (en) * | 2002-10-25 | 2004-11-11 | Wolfman Neil M. | ActRIIB fusion polypeptides and uses therefor |
AU2013216655B2 (en) * | 2002-12-20 | 2016-05-26 | Amgen Inc. | Binding agents which inhibit myostatin |
NZ541253A (en) | 2002-12-20 | 2010-03-26 | Amgen Inc | Peptide binding agents which inhibit myostatin |
US9068234B2 (en) * | 2003-01-21 | 2015-06-30 | Ptc Therapeutics, Inc. | Methods and agents for screening for compounds capable of modulating gene expression |
AU2004245025A1 (en) * | 2003-06-02 | 2004-12-16 | Wyeth | Use of myostatin (GDF8) inhibitors in conjunction with corticosteroids for treating neuromuscular disorders |
JP5335239B2 (ja) * | 2004-09-30 | 2013-11-06 | マイオスティン・セラピューティクス・プロプライエタリー・リミテッド | ミオスタチンアイソフォーム |
EP1864138A2 (en) * | 2005-03-23 | 2007-12-12 | Wyeth | Detection of gdf-8 modulating agents |
WO2007024535A2 (en) | 2005-08-19 | 2007-03-01 | Wyeth | Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8-associated disorders |
WO2007044411A2 (en) | 2005-10-06 | 2007-04-19 | Eli Lilly And Company | Anti-myostatin antibodies |
UA92504C2 (en) | 2005-10-12 | 2010-11-10 | Эли Лилли Энд Компани | Anti-myostatin monoclonal antibody |
MX2008007324A (es) * | 2005-12-06 | 2009-03-04 | Amgen Inc | Usos de antagonistas de miostatina. |
EP4342995A3 (en) | 2006-03-31 | 2024-05-15 | Chugai Seiyaku Kabushiki Kaisha | Methods for controlling blood pharmacokinetics of antibodies |
CA2693378C (en) | 2006-08-03 | 2020-04-14 | Orico Limited | Myostatin antagonists |
JP5058261B2 (ja) * | 2006-09-05 | 2012-10-24 | イーライ リリー アンド カンパニー | 抗ミオスタチン抗体 |
WO2009041643A1 (ja) | 2007-09-26 | 2009-04-02 | Chugai Seiyaku Kabushiki Kaisha | Cdrのアミノ酸置換により抗体の等電点を改変する方法 |
JP4954326B2 (ja) | 2008-04-11 | 2012-06-13 | 中外製薬株式会社 | 複数分子の抗原に繰り返し結合する抗原結合分子 |
JP2012021973A (ja) * | 2010-06-15 | 2012-02-02 | Nitto Denko Corp | Sprセンサセルおよびsprセンサ |
EP4231014A3 (en) | 2010-11-30 | 2024-03-20 | Chugai Seiyaku Kabushiki Kaisha | Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly |
WO2013186719A1 (en) | 2012-06-15 | 2013-12-19 | Pfizer Inc. | Improved antagonist antibodies against gdf-8 and uses therefor |
NZ705370A (en) | 2012-08-24 | 2018-06-29 | Chugai Pharmaceutical Co Ltd | Fcγriib-specific fc region variant |
US11236168B2 (en) | 2012-08-24 | 2022-02-01 | Chugai Seiyaku Kabushiki Kaisha | Mouse FcγammaRII-specific Fc antibody |
MY172863A (en) | 2012-09-13 | 2019-12-13 | Bristol Myers Squibb Co | Fibronectin based scaffold domain proteins that bind to myostatin |
KR102318483B1 (ko) | 2013-04-02 | 2021-10-27 | 추가이 세이야쿠 가부시키가이샤 | Fc영역 개변체 |
WO2014168973A2 (en) | 2013-04-08 | 2014-10-16 | President And Fellows Of Harvard College | Methods and compositions for rejuvenating skeletal muscle stem cells |
AU2014262843B2 (en) | 2013-05-06 | 2017-06-22 | Scholar Rock, Inc. | Compositions and methods for growth factor modulation |
EP3881859B1 (en) | 2013-06-11 | 2024-03-06 | President and Fellows of Harvard College | Compositions for increasing neurogenesis and angiogenesis |
CA3005158A1 (en) * | 2014-11-06 | 2016-05-12 | Scholar Rock, Inc. | Anti-pro/latent-myostatin antibodies and uses thereof |
WO2016073879A2 (en) * | 2014-11-06 | 2016-05-12 | Scholar Rock, Inc. | Transforming growth factor-related antibodies and uses thereof |
MY181199A (en) | 2014-12-19 | 2020-12-21 | Chugai Pharmaceutical Co Ltd | Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use |
CN107108729A (zh) | 2015-02-05 | 2017-08-29 | 中外制药株式会社 | 包含离子浓度依赖性的抗原结合结构域的抗体,fc区变体,il‑8‑结合抗体,及其应用 |
IL258121B2 (en) | 2015-09-15 | 2024-01-01 | Scholar Rock Inc | Antipro/latent myostatin antibodies and their uses |
US11359009B2 (en) | 2015-12-25 | 2022-06-14 | Chugai Seiyaku Kabushiki Kaisha | Anti-myostatin antibodies and methods of use |
EP3949979A1 (en) | 2016-01-06 | 2022-02-09 | President and Fellows of Harvard College | Treatment with gdf11 prevents weight gain, improves glucose tolerance and reduces hepatosteatosis |
MX2018008369A (es) | 2016-01-08 | 2019-05-15 | Scholar Rock Inc | Anticuerpos de anti-miostatina pro/latente y metodo de uso de los mismos. |
EP3785728A3 (en) | 2016-06-13 | 2021-04-28 | Scholar Rock, Inc. | Use of myostatin inhibitors and combination therapies |
KR20230079499A (ko) | 2016-08-05 | 2023-06-07 | 추가이 세이야쿠 가부시키가이샤 | Il-8 관련 질환의 치료용 또는 예방용 조성물 |
DK3565592T3 (da) | 2017-01-06 | 2023-05-01 | Scholar Rock Inc | Behandling af stofskiftesygdomme ved inhibering af myostatinaktivering |
CN111793123B (zh) * | 2019-04-08 | 2022-03-08 | 中国农业大学 | 一种肌肉生长抑制素mstn的突变体及其应用 |
CN110192624A (zh) * | 2019-07-05 | 2019-09-03 | 福建冠丰生物科技有限公司 | 一种海参牡蛎营养物口服含片及其制备方法 |
EP4179333A1 (en) | 2020-07-10 | 2023-05-17 | Institut Pasteur | Use of gdf11 to diagnose and treat anxiety and depression |
WO2024107652A1 (en) * | 2022-11-14 | 2024-05-23 | John Mansell | Myostatin inhibition |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US732575A (en) * | 1902-10-04 | 1903-06-30 | Louis G Mayer | Carriage-spring. |
US4036945A (en) | 1976-05-03 | 1977-07-19 | The Massachusetts General Hospital | Composition and method for determining the size and location of myocardial infarcts |
US4331647A (en) | 1980-03-03 | 1982-05-25 | Goldenberg Milton David | Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers |
US4873191A (en) | 1981-06-12 | 1989-10-10 | Ohio University | Genetic transformation of zygotes |
US4766073A (en) * | 1985-02-25 | 1988-08-23 | Zymogenetics Inc. | Expression of biologically active PDGF analogs in eucaryotic cells |
US5206347A (en) | 1985-08-06 | 1993-04-27 | La Jolla Cancer Research Foundation | Isolation and use of receptors binding to a peptide column |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5011912A (en) | 1986-12-19 | 1991-04-30 | Immunex Corporation | Hybridoma and monoclonal antibody for use in an immunoaffinity purification system |
US5162215A (en) | 1988-09-22 | 1992-11-10 | Amgen Inc. | Method of gene transfer into chickens and other avian species |
US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
US5350836A (en) * | 1989-10-12 | 1994-09-27 | Ohio University | Growth hormone antagonists |
US5225212A (en) | 1989-10-20 | 1993-07-06 | Liposome Technology, Inc. | Microreservoir liposome composition and method |
DE69024369T2 (de) | 1989-11-22 | 1996-06-13 | Genentech Inc | Latenz assoziierte peptide und deren verwendung |
US5283173A (en) | 1990-01-24 | 1994-02-01 | The Research Foundation Of State University Of New York | System to detect protein-protein interactions |
ATE149841T1 (de) | 1990-01-26 | 1997-03-15 | Immunomedics Inc | Impfstoffe gegen krebs und infektionskrankheiten |
AU7312891A (en) | 1990-02-12 | 1991-09-03 | Board Of Regents, The University Of Texas System | Satellite cell proliferation in adult skeletal muscle |
US5265030A (en) | 1990-04-24 | 1993-11-23 | Scripps Clinic And Research Foundation | System and method for determining three-dimensional structures of proteins |
US5750342A (en) | 1990-06-11 | 1998-05-12 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands of tissue target |
US5264563A (en) | 1990-08-24 | 1993-11-23 | Ixsys Inc. | Process for synthesizing oligonucleotides with random codons |
US5314695A (en) | 1990-11-13 | 1994-05-24 | Corvas International, Inc. | Tissue factor based prothrombin time reagent |
US5885794A (en) | 1991-05-10 | 1999-03-23 | The Salk Institute For Biological Studies | Recombinant production of vertebrate activin receptor polypeptides and identification of receptor DNAs in the activin/TGF-β superfamily |
WO1993001484A1 (en) | 1991-07-11 | 1993-01-21 | The Regents Of The University Of California | A method to identify protein sequences that fold into a known three-dimensional structure |
US5585479A (en) | 1992-07-24 | 1996-12-17 | The United States Of America As Represented By The Secretary Of The Navy | Antisense oligonucleotides directed against human ELAM-I RNA |
JP3415643B2 (ja) | 1992-12-04 | 2003-06-09 | 株式会社ミノファーゲン製薬 | 筋ジストロフィー症治療薬 |
US5395619A (en) | 1993-03-03 | 1995-03-07 | Liposome Technology, Inc. | Lipid-polymer conjugates and liposomes |
US20030074680A1 (en) | 1993-03-19 | 2003-04-17 | Johns Hopkins University School Of Medicine | Growth differentiation factor-8 |
US6465239B1 (en) * | 1993-03-19 | 2002-10-15 | The John Hopkins University School Of Medicine | Growth differentiation factor-8 nucleic acid and polypeptides from aquatic species and non-human transgenic aquatic species |
US5994618A (en) | 1997-02-05 | 1999-11-30 | Johns Hopkins University School Of Medicine | Growth differentiation factor-8 transgenic mice |
US7393682B1 (en) | 1993-03-19 | 2008-07-01 | The Johns Hopkins University School Of Medicine | Polynucleotides encoding promyostatin polypeptides |
EP1333035A3 (en) * | 1993-03-19 | 2004-07-07 | The Johns Hopkins University School Of Medicine | Growth differentiation factor-8 |
US6607884B1 (en) | 1993-03-19 | 2003-08-19 | The Johns Hopkins University School Of Medicine | Methods of detecting growth differentiation factor-8 |
JP3681069B2 (ja) * | 1993-05-12 | 2005-08-10 | ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー | Bmp−11組成物 |
US7332575B2 (en) | 1994-03-18 | 2008-02-19 | The Johns Hopkins University School Of Medicine | Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
CA2194660C (en) | 1994-07-08 | 2009-09-29 | Se-Jin Lee | Growth differentiation factor-11 |
US5616561A (en) | 1995-03-31 | 1997-04-01 | Regents Of The University Of California | TGF-β antagonists as mitigators of radiation-induced tissue damage |
JP4484967B2 (ja) * | 1995-06-06 | 2010-06-16 | ベス イスラエル ディーコネス メディカル センター | Dna診断試験の方法及び装置 |
US5622699A (en) | 1995-09-11 | 1997-04-22 | La Jolla Cancer Research Foundation | Method of identifying molecules that home to a selected organ in vivo |
DE19626982C1 (de) | 1996-07-04 | 1997-09-25 | Siemens Ag | Elektromagnetisches Relais und Verfahren zu dessen Herstellung |
US5776689A (en) | 1996-07-19 | 1998-07-07 | The Regents Of The University Of California | Protein recruitment system |
WO1998033887A1 (en) | 1997-02-05 | 1998-08-06 | The Johns Hopkins University School Of Medicine | Growth differentiation factor-8 |
US5827533A (en) | 1997-02-06 | 1998-10-27 | Duke University | Liposomes containing active agents aggregated with lipid surfactants |
US5933819C1 (en) | 1997-05-23 | 2001-11-13 | Scripps Research Inst | Prediction of relative binding motifs of biologically active peptides and peptide mimetics |
US6103466A (en) * | 1997-07-14 | 2000-08-15 | University Of Liege | Double-muscling in mammals |
DE69841139D1 (de) | 1997-07-14 | 2009-10-22 | Univ Liege | Mutationen im myostatingen steigern muskelmasse in säugetieren |
US6696260B1 (en) | 1997-08-01 | 2004-02-24 | The Johns Hopkins University School Of Medicine | Methods to identify growth differentiation factor (GDF) binding proteins |
US6656475B1 (en) | 1997-08-01 | 2003-12-02 | The Johns Hopkins University School Of Medicine | Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
AU8666398A (en) | 1997-08-01 | 1999-02-22 | Johns Hopkins University School Of Medicine, The | Methods to identify growth differentiation factor (gdf) receptors |
US6891082B2 (en) | 1997-08-01 | 2005-05-10 | The Johns Hopkins University School Of Medicine | Transgenic non-human animals expressing a truncated activintype II receptor |
US5885779A (en) | 1997-09-09 | 1999-03-23 | University Of British Columbia | Repressed trans-activator system for characterization of protein-protein interactions |
DE19800422A1 (de) | 1998-01-08 | 1999-07-15 | Bosch Gmbh Robert | Bremsvorrichtung für Fahrzeuge |
AU2586199A (en) | 1998-02-05 | 1999-08-23 | Johns Hopkins University School Of Medicine, The | Growth differentiation factor-8 |
US6369201B1 (en) | 1998-02-19 | 2002-04-09 | Metamorphix International, Inc. | Myostatin multimers |
US6004937A (en) | 1998-03-09 | 1999-12-21 | Genetics Institute, Inc. | Use of follistatin to modulate growth and differentiation factor 8 [GDF-8] and bone morphogenic protein 11 [BMP-11] |
JP4544742B2 (ja) | 1998-05-06 | 2010-09-15 | メタモーフイクス・インコーポレーテツド | Gdf−8の阻害による糖尿病の処置法 |
AU772694B2 (en) * | 1999-01-21 | 2004-05-06 | Metamorphix International, Inc. | Growth differentiation factor inhibitors and uses therefor |
EA005248B1 (ru) * | 1999-07-20 | 2004-12-30 | Фармекса А/С | Способ отрицательной регуляции активности gdf-8 |
-
2000
- 2000-11-07 US US09/708,693 patent/US7393682B1/en not_active Expired - Fee Related
-
2001
- 2001-07-26 AU AU8079901A patent/AU8079901A/xx active Pending
- 2001-07-26 IL IL15397001A patent/IL153970A0/xx unknown
- 2001-07-26 NZ NZ542696A patent/NZ542696A/en not_active IP Right Cessation
- 2001-07-26 CA CA002416260A patent/CA2416260A1/en not_active Abandoned
- 2001-07-26 CN CNB018149073A patent/CN100429225C/zh not_active Expired - Fee Related
- 2001-07-26 JP JP2002515196A patent/JP5149478B2/ja not_active Expired - Fee Related
- 2001-07-26 BR BRPI0112785A patent/BRPI0112785B1/pt not_active IP Right Cessation
- 2001-07-26 EP EP10185291A patent/EP2360259A3/en not_active Withdrawn
- 2001-07-26 NZ NZ523672A patent/NZ523672A/en not_active IP Right Cessation
- 2001-07-26 MX MXPA03000786A patent/MXPA03000786A/es active IP Right Grant
- 2001-07-26 AU AU2001280799A patent/AU2001280799B2/en not_active Ceased
- 2001-07-26 EP EP01959217A patent/EP1303534A4/en not_active Withdrawn
- 2001-07-26 WO PCT/US2001/023510 patent/WO2002009641A2/en active Application Filing
- 2001-07-26 CN CN200710199696.5A patent/CN101261277B/zh not_active Expired - Fee Related
- 2001-07-26 PL PL365780A patent/PL210158B1/pl unknown
- 2001-07-27 AR ARP010103594A patent/AR030307A1/es not_active Application Discontinuation
-
2003
- 2003-01-15 IL IL153970A patent/IL153970A/en active IP Right Grant
- 2003-01-17 ZA ZA200300483A patent/ZA200300483B/en unknown
-
2008
- 2008-07-01 US US12/166,035 patent/US8323964B2/en not_active Expired - Fee Related
-
2011
- 2011-01-26 US US13/014,623 patent/US20110239317A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN1449409A (zh) | 2003-10-15 |
ZA200300483B (en) | 2004-02-19 |
JP2004504826A (ja) | 2004-02-19 |
WO2002009641A9 (en) | 2003-03-20 |
US20110239317A1 (en) | 2011-09-29 |
BRPI0112785B1 (pt) | 2016-07-12 |
US20090017522A1 (en) | 2009-01-15 |
AR030307A1 (es) | 2003-08-20 |
CN101261277B (zh) | 2014-03-12 |
NZ542696A (en) | 2008-02-29 |
EP2360259A2 (en) | 2011-08-24 |
IL153970A (en) | 2012-08-30 |
EP2360259A3 (en) | 2011-11-16 |
US7393682B1 (en) | 2008-07-01 |
JP5149478B2 (ja) | 2013-02-20 |
PL365780A1 (en) | 2005-01-10 |
CN100429225C (zh) | 2008-10-29 |
IL153970A0 (en) | 2003-07-31 |
WO2002009641A2 (en) | 2002-02-07 |
WO2002009641A3 (en) | 2002-05-10 |
BR0112785A (pt) | 2003-07-01 |
EP1303534A2 (en) | 2003-04-23 |
CN101261277A (zh) | 2008-09-10 |
AU2001280799B2 (en) | 2006-06-08 |
AU8079901A (en) | 2002-02-13 |
EP1303534A4 (en) | 2004-09-01 |
CA2416260A1 (en) | 2002-02-07 |
PL210158B1 (pl) | 2011-12-30 |
NZ523672A (en) | 2006-02-24 |
US8323964B2 (en) | 2012-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03000786A (es) | Peptidos de promiostatina y metodos de usar los mismos. | |
WO1996017924A3 (en) | Novel hedgehog-derived polypeptides | |
IL212140A (en) | Antibodies against polypeptides acpl | |
IL195812A0 (en) | Human tslp dna and polypeptides | |
SI1346034T1 (sl) | POLIPEPTID PROTEAZE, KI CEPI VON WILLEBRANDOV FAKTOR (vWF), NUKLEINSKA KISLINA, KI KODIRA POLIPEPTID, IN UPORABA POLIPEPTIDA | |
IL110829A0 (en) | Hybrid toxin fragments and toxins comprising them | |
NZ616594A (en) | Antibodies to opgl | |
PL344752A1 (en) | Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof | |
ZA953629B (en) | Soluble polypeptidic fragments of lag-3 protein method of production thereof therapeutic composition anti-idiotype antibodies | |
WO2002016418A3 (en) | An iap binding peptide or polypeptide and methods of using the same | |
IL128829A0 (en) | Improved solid-phase peptide and agent for use in such synthesis | |
ES2165881T3 (es) | Constructo de adn que codifica el peptido señal yap3. | |
ATE398179T1 (de) | Von rna polymerasen abstammende polypeptide und ihre verwendungen | |
DE60217377D1 (en) | Durch thrombin spaltbare chimäre proteine | |
DK1165806T3 (da) | Phosphataser med forbedret phytaseaktivitet | |
WO2003018611A3 (en) | Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer | |
DE60134230D1 (de) | Substraten und nachweise zur wirksamkeit von beta-secretase | |
WO2002060917A3 (en) | Method to treat hemophilia | |
EP0546087A4 (es) | ||
IL156799A0 (en) | Peptides having affinity for the gp120 viral protein and use thereof | |
EA200100314A1 (ru) | Пептидные фрагменты холерного экзотоксина в или энтеротоксина в в качестве адъювантов вакцины | |
AU1717402A (en) | Glucuronyl c5-epimerase, dna encoding the same and uses thereof | |
MXPA02012030A (es) | Sustratos peptidicos de metalorpoteasas y metodos. | |
IL139272A0 (en) | New peptide fragments for protein purification | |
MX9804053A (es) | Malation carboxilesterasa. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |